Home LiteratureArticle Details
PMID: 10196463 Published · ppublish English Clinical Trial Controlled Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type.

Brain research ·Vol. 824 ·No. 2 ·1999-04-10 ·Pages 300-3

Yamamoto-Sasaki M, Ozawa H, Saito T, Rösler M, Riederer P

Abstract

Cyclic AMP (cAMP) is disrupted in the brain in dementia of the Alzheimer type (DAT). We investigated whether the cAMP reduction is accompanied by an alteration in the cAMP response element binding protein (CREB) downstream in DAT and control hippocampi. Immunoreactivity of pCREB was significantly decreased in DAT, while total CREB level was unchanged. These findings indicate that impaired cAMP signaling may contribute to the pathophysiology of the disease.

MeSH Terms
Adult Aged Alzheimer Disease/metabolism Cyclic AMP Response Element-Binding Protein/metabolism Female Hippocampus/metabolism Humans Linear Models Male Middle Aged Nerve Tissue Proteins/metabolism Phosphorylation
Chemicals
Cyclic AMP Response Element-Binding Protein Nerve Tissue Proteins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Yamamoto-Sasaki M
Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Füchsleinstrasse 15, 97080, Würzburg, Germany. megumi.sasaki@mail.uni-wuerzburg.de
Ozawa H
Saito T
Rösler M
Riederer P
Article Info
Journal
Brain research
Abbr.
Brain Res
ISSN
0006-8993
Published
1999-04-10
Pages
300-3
Language
English
Region
Netherlands
NLM ID
0045503
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com